4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001638599-18-000678
Options or other derivatives
- Chief Commercial Officer acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Smolinski Stephen · Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-06-15 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +80,000 | $12.75 | 2028-06-14 | 80,000 | 80,000 | D |
Loading xslF345X03/doc4_5479.xml…